JP2021519764A5 - - Google Patents
Info
- Publication number
- JP2021519764A5 JP2021519764A5 JP2020552324A JP2020552324A JP2021519764A5 JP 2021519764 A5 JP2021519764 A5 JP 2021519764A5 JP 2020552324 A JP2020552324 A JP 2020552324A JP 2020552324 A JP2020552324 A JP 2020552324A JP 2021519764 A5 JP2021519764 A5 JP 2021519764A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- substituted
- membered
- nhc
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862649428P | 2018-03-28 | 2018-03-28 | |
| US62/649,428 | 2018-03-28 | ||
| PCT/US2019/023917 WO2019190999A1 (en) | 2018-03-28 | 2019-03-25 | Method of treating fibrotic disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021519764A JP2021519764A (ja) | 2021-08-12 |
| JP2021519764A5 true JP2021519764A5 (enExample) | 2022-03-31 |
Family
ID=68060720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020552324A Pending JP2021519764A (ja) | 2018-03-28 | 2019-03-25 | 線維性疾患を処置する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210113560A1 (enExample) |
| EP (1) | EP3774785A4 (enExample) |
| JP (1) | JP2021519764A (enExample) |
| KR (1) | KR20200139721A (enExample) |
| CN (1) | CN112166111A (enExample) |
| AU (1) | AU2019242595A1 (enExample) |
| BR (1) | BR112020019325A2 (enExample) |
| CA (1) | CA3093749A1 (enExample) |
| CL (1) | CL2020002465A1 (enExample) |
| IL (1) | IL277500A (enExample) |
| MX (1) | MX2020010034A (enExample) |
| RU (1) | RU2020130012A (enExample) |
| SG (1) | SG11202008773PA (enExample) |
| TW (1) | TW202003503A (enExample) |
| WO (1) | WO2019190999A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017292646A1 (en) | 2016-07-05 | 2019-02-07 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| US10934261B2 (en) | 2016-09-28 | 2021-03-02 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| CA3095164A1 (en) * | 2018-03-28 | 2019-10-03 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| EP3820864A4 (en) * | 2018-06-28 | 2022-03-30 | Blade Therapeutics, Inc. | METHOD OF TREATMENT OF HEPATIC FIBROSIS USING CALPAIN INHIBITORS |
| BR112022025037A2 (pt) | 2020-06-10 | 2023-02-14 | Aligos Therapeutics Inc | Compostos antivirais para tratar infecções por coronavírus, picornavírus e norovírus |
| WO2023283256A1 (en) | 2021-07-09 | 2023-01-12 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| US12065428B2 (en) | 2021-09-17 | 2024-08-20 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| AU2023303408A1 (en) | 2022-07-06 | 2024-12-19 | Aligos Therapeutics, Inc. | Anti-viral compounds |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4544993A (en) * | 1992-06-24 | 1994-01-24 | Cortex Pharmaceuticals, Inc. | Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| EP0699074B1 (en) * | 1993-04-30 | 2002-11-13 | Merck & Co. Inc. | Thrombin inhibitors |
| AU5526098A (en) * | 1996-12-23 | 1998-07-17 | Biochem Pharma Inc. | Bicyclic thrombin inhibitors |
| TR199902692T2 (xx) * | 1997-05-02 | 2000-07-21 | Akzo Nobel N.V. | Serin proteaz inhibit�rleri. |
| DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
| US20100094755A1 (en) * | 2008-10-09 | 2010-04-15 | Nelnet Business Solutions, Inc. | Providing payment data tokens for online transactions utilizing hosted inline frames |
| TWI519530B (zh) * | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途 |
| MX2013006419A (es) * | 2010-12-09 | 2013-12-16 | Abbvie Inc | Compuestos carboxamida y su uso como inhibidores de calpaina v. |
| US9150545B2 (en) * | 2012-04-03 | 2015-10-06 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
| WO2014085633A1 (en) * | 2012-11-30 | 2014-06-05 | Novomedix, Llc | Substituted biaryl sulfonamides and the use thereof |
| RU2020111934A (ru) * | 2013-10-08 | 2020-04-29 | Промедиор, Инк. | Способы лечения фиброзного рака |
| US10934261B2 (en) * | 2016-09-28 | 2021-03-02 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| CA3095164A1 (en) * | 2018-03-28 | 2019-10-03 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
-
2019
- 2019-03-25 CN CN201980035685.4A patent/CN112166111A/zh active Pending
- 2019-03-25 JP JP2020552324A patent/JP2021519764A/ja active Pending
- 2019-03-25 MX MX2020010034A patent/MX2020010034A/es unknown
- 2019-03-25 KR KR1020207030882A patent/KR20200139721A/ko not_active Ceased
- 2019-03-25 US US17/041,611 patent/US20210113560A1/en not_active Abandoned
- 2019-03-25 AU AU2019242595A patent/AU2019242595A1/en not_active Abandoned
- 2019-03-25 WO PCT/US2019/023917 patent/WO2019190999A1/en not_active Ceased
- 2019-03-25 BR BR112020019325-9A patent/BR112020019325A2/pt not_active IP Right Cessation
- 2019-03-25 SG SG11202008773PA patent/SG11202008773PA/en unknown
- 2019-03-25 EP EP19777960.6A patent/EP3774785A4/en not_active Withdrawn
- 2019-03-25 CA CA3093749A patent/CA3093749A1/en active Pending
- 2019-03-25 RU RU2020130012A patent/RU2020130012A/ru unknown
- 2019-03-28 TW TW108111018A patent/TW202003503A/zh unknown
-
2020
- 2020-09-22 IL IL277500A patent/IL277500A/en unknown
- 2020-09-24 CL CL2020002465A patent/CL2020002465A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3031577T3 (en) | Treatment of type 2 diabetes with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof | |
| JP2021519312A5 (enExample) | ||
| JP2009514874A5 (enExample) | ||
| JP2006182786A5 (enExample) | ||
| EA022040B1 (ru) | Применение бетанехола для лечения ксеростомии | |
| JP2008501753A5 (enExample) | ||
| RU2020130012A (ru) | Способ лечения фиброзного заболевания | |
| KR20170141757A (ko) | 테트라하이드로나프티리디닐 프로피온산 유도체 및 이의 용도 | |
| CN110169962B (zh) | 用于治疗癌症的氧烯洛尔组合物 | |
| JP2021525787A5 (enExample) | ||
| JP2002537258A5 (enExample) | ||
| US20160184252A1 (en) | Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same | |
| KR20010101922A (ko) | 고혈압 치료를 위한 약제학적 조성물 | |
| JP2025027020A (ja) | 患者において血清リン酸塩を低下させるための組み合わせ | |
| JP4011114B2 (ja) | 脳浮腫抑制剤 | |
| JP2023517919A5 (enExample) | ||
| JP2004517808A5 (enExample) | ||
| JP2020040978A (ja) | サルコイドーシスを処置するための１，３−プロパンジスルホン酸またはその薬学的に許容される塩の使用 | |
| KR101174930B1 (ko) | ２-아미노-１,３-프로판디올 화합물의 화합물 제제 | |
| JP4824573B2 (ja) | 腎不全、腎疾患または腎障害、特に糖尿病患者におけるこれらの治療のための医薬組成物 | |
| EP3010508B1 (en) | Combination of ro5503781, capecitabine and oxaliplatin for cancer therapy | |
| CN116421607A (zh) | 1,2,4三唑并4,3-b哒嗪衍生物在制备抗特发性肺纤维化药物中的应用 | |
| JPH08165236A (ja) | 下痢の予防及び治療剤 | |
| JP2005529110A5 (enExample) | ||
| JP2020520904A5 (enExample) |